EFFECTIVENESS OF SINGLE DOSE ORAL DEXAMETHASONE VERSUS MULTIDOSE PREDNISOLONE FOR TREATMENT OF ACUTE EXACERBATIONS OF ASTHMA AMONG CHILDREN ATTENDING THE EMERGENCY DEPARTMENT OF CHILDREN HOSPITAL, ISLAMABAD
NCT05850143 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 192
Last updated 2023-05-09
Summary
In this Study i'll compare the effectiveness of two drugs used in acute exacerbation of asthma by their sideffects, complaince and improvement in the PRAM score. The better one would be adapted in our clinical practice.
Conditions
- Asthma in Children
Interventions
- DRUG
-
Oral Dexamethasone a longer and potent corticosteroid with lesser sideffects and good compliance
- DRUG
-
Prednisolone
Oral Multidose Prednisolone
Sponsors & Collaborators
-
DR. MOHAMMAD ALI ARIF
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 2 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-26
- Primary Completion
- 2023-12-26
- Completion
- 2023-12-26
Countries
- Pakistan
Study Locations
More Related Trials
-
Phase III Randomized, Double-Blind Study of Dexamethasone Vs Dexamethasone/Methylprednisolone Vs Placebo for Bronchopulmonary Dysplasia
NCT00004785 ·Status: COMPLETED ·Phase: PHASE3
-
Dexamethasone Regimens for Prophylaxis of Paclitaxel-associated Hypersensitivity Reaction
NCT02349763 ·Status: COMPLETED ·Phase: PHASE3
-
Dexamethasone Compared to Ondansetron and Dexamethasone for Prophylaxis of Postoperative Vomiting in Children
NCT01297010 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Two Regimens of Dexamethasone in the Prevention of Hypersensitivity Reactions to Paclitaxel, a Pilot Study
NCT01797991 ·Status: COMPLETED ·Phase: NA
-
Schedules of Dexamethasone in Patients Incorrectly Taking Dexamethasone Premedication (REaCT-dexamethasone)
NCT02815319 ·Status: COMPLETED ·Phase: PHASE4
-
MEtoclopramide, DExamethasone or Axoli to Prevent or Delay Chemotherapy-induced Nausea and Vomiting in Moderately Emetogenic Non-AC-based Chemotherapy
NCT02135510 ·Status: COMPLETED ·Phase: PHASE3
-
Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)
NCT00687011 ·Status: COMPLETED ·Phase: PHASE4
-
Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients
NCT04508400 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Dexamethasone Prevention for Patients of Ovarian Hyperstimulation Syndrome
NCT02846493 ·Status: UNKNOWN ·Phase: PHASE2
-
Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children
NCT06208917 ·Status: RECRUITING ·Phase: PHASE3
-
Dexamethasone-induced Hiccup in Chemotherapy Patients Treated by Methylprednisolone Rotation
NCT01974024 ·Status: COMPLETED ·Phase: PHASE3
-
High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy
NCT03125941 ·Status: COMPLETED ·Phase: PHASE4
-
Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy
NCT00152867 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Omission of Dexamethasone in Premedication Regimens During Paclitaxel Treatment
NCT06118710 ·Status: RECRUITING ·Phase: PHASE4
-
Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting
NCT01975727 ·Status: TERMINATED ·Phase: PHASE2
-
Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease
NCT00391170 ·Status: COMPLETED ·Phase: PHASE2
-
Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer
NCT02550795 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral Density
NCT06367725 ·Status: RECRUITING
-
Dexamethasone in Controlling Dyspnea in Patients With Cancer
NCT03367156 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Antiemetic Efficacy and Safety of Dexamethasone in Obstetric Surgical Patients
NCT01028547 ·Status: COMPLETED ·Phase: NA
-
Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and Dexamethasone
NCT02532634 ·Status: COMPLETED ·Phase: PHASE4
-
Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy
NCT02550119 ·Status: TERMINATED ·Phase: NA
-
the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy
NCT04430361 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting
NCT05012033 ·Status: RECRUITING
-
RCT on the Efficacy of Dexamethasone Versus Methyl Prednisolone in Covid-19 Infected Patients With High Oxygen Flow
NCT05062681 ·Status: UNKNOWN ·Phase: PHASE4